W. L. Gore Receives FDA Approval for Endoprosthesis Components

W. L. Gore & Associates has announced it has received FDA approval for new endoprosthesis components, according to a news release.

Advertisement

 

The components are a new large diameter 35 mm trunk-ipsilateral leg and 36 mm aortic extender components, as well as the lower profile 31 mm diameter trunk-ipsilateral leg and 32 mm aortic extender components of the GORE EXCLUDER AAA endoprosthesis.

 

The new components are intended to provide physicians with an endovascular option to treat abdominal aortic aneurysms. The GORE EXCLUDER AAA endoprosthesis is an endovascular stent-graft that is designed to seal off the aneurysm and create a new path for blood flow.

 

“Expanding our AAA sizing portfolio means that Gore can now offer physicians a wider range of components using the preferred infrarenal placement on the lowest profile sheath available today,” said Ryan Takeuchi, Gore aortic business leader, in the release. “All of our innovative product enhancements, such as the ones announced today, are driven by Gore’s commitment to help physicians provide the best possible patient care.”

 

W. L. Gore & Associates is headquartered in Newark, Del.

 

Related Articles on FDA Clearances:

Philips Respironics Receives FDA Clearance for Airway Clearance Technology

BioPhotas Receives FDA Clearance of Light Therapy Device

Riverain Technologies Receives FDA Clearance for ClearRead +Confirm Software

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.